BTL Aesthetics celebrated the launch of their revolutionary facial treatment, EMFACE®, cruising in style around Sydney Harbour with a glamorous who’s who of aesthetic medical practitioners from across Australia and New Zealand.
A champagne tower, caviar, lavish seafood, fine wines and a crowd ready to celebrate were aboard ‘The Jackson’ on a balmy Friday night for a sunset cruise around Sydney Harbour and the opportunity to learn first-hand about EMFACE®.
MC, Kathryn Eisman, introduced both the Australian and International BTL teams, followed by Plastic Surgeons Dr Brian Kinney (Beverly Hills), Dr Steven Liew (Sydney) and Cosmetic Physician Dr Sam Patel (Chicago) officially unveiling EMFACE®. “This innovative device is set to change the face of the Aesthetics Industry and shift the treatment paradigm of facial aging,” predicts Dr Sam Patel.
“EMFACE® helps restore more youthful function to facial muscles,” Dr Brian Kinney explains, “and it promotes more youthful-looking skin, which doesn’t just look better, it functions more like it used to. It’s very easy to explain this to people and they love the concepts, especially if they’re averse to more invasive treatments or injectables, which many people are.”
“For the last two decades, clinicians have focused on treating the signs and effects of the ageing process rather than the root cause. Anti-wrinkle and filler injectables, while super effective, are merely dealing with the signs of ageing. With EMFACE® technology, we are targeting the causes of ageing; namely, loss of muscular tone of the facial muscle, especially those responsible for lifting the eyebrow, cheeks and the lower face. These are the elevators of the face,” says Dr Steven Liew.
About EMFACE
EMFACE® is the world’s first and only non-invasive hands-free device to simultaneously treat the facial muscles, connective tissues and skin without any needles or downtime in just 20 minutes. The patented technology simultaneously emits both synchronised radiofrequency and HIFES™ energy to remodel the face.
The radio frequency heats collagen and elastin fibres while the HIFES™ stimulation emits thousands of pulses per session to contract the specific delicate facial muscles, resulting in a restored face lifting effect.
As an innovative hands-free device, EMFACE® does not rely on the operator’s skills to provide reproducible results. The applicators are designed to target the forehead, eyebrows, cheeks and jawline simultaneously and are perfect for needle-phobic patients. EMFACE® treatment offers a slimmer and more defined jawline, better contour with fuller and higher cheeks, elevated brows, and overall facial rejuvenation including wrinkle reduction and improved skin tone and texture.
The recommended treatment course for EMFACE® therapy is four 20-minute sessions, completed 2-14 days apart. The findings from the clinical studies concluded that participants who completed the recommended treatment course experienced, on average, a 37% reduction in wrinkles1, 30% increase in facial muscle tone2, and 23% lifting effect3 – with optimal results seen 6-12 weeks after final treatment and 95% patient satisfaction1,3, supporting the claims that the results of EMFACE® treatments result in less wrinkles and more lift.
The 2-in-1 procedure is needle- and injectable-free and requires no pre- or post-preparation or downtime.
About BTL
Marking 30 years of industry-leading innovation and development of disruptive technologies, BTL AESTHETICS has become one of the world’s foremost medical and aesthetic equipment manufacturers.
The business has over 2,800 employees across 71 countries, with 420 engineers in Research and Development based in five countries. Years of development resulted in a number of patents being granted and helped BTL in expanding the diversity of healthcare services that can improve patients’ lives.
BTL AESTHETICS is renowned for clinical excellence, cutting edge and state-of-the-art technology. Backed by dozens of peer-reviewed clinical studies, proven satisfaction rates as well as ROI .
The business has revolutionised non-invasive solutions for face, body shaping, cellulite, skin tightening and other medical aesthetic treatments with devices such as EMSCULPT NEO®, EMSCULPT®, EMSELLA ®, EMTONE® and EXILIS® and most recently the highly anticipated EMFACE®.
Clinical references:
- Halaas, Y & Gentile, R. Novel Approach to Facial Rejuvenation by Treating Skin and Muscle Tissue for Wrinkles Reduction: Preliminary Data from Multicenter Clinical Trial. Accepted for American Academy of Facial Plastic and Reconstructive Surgery 2022 Annual Meeting, Washington, DC.
- Kinney, B, Bernardy, J & Jarosova, R. Novel technology for Facial Muscle Stimulation Combined with Synchronized Radiofrequency Induces structural changes in Muscles tissue: Porcine Histology Study. Presented at 41st Annual Conference of the American Society for Laser Medicine and Surgery. 2022; San Diego, CA.
- Kinney, B. & Boyd, C. Novel Approach to Facial Rejuvenation by Treating Skin and Muscle Tissue for Facial Lifting: Preliminary Data from Multicenter Clinical Trial. Accepted at American Academy of Facial Plastic and Reconstructive Surgery 2022 Annual Meeting, Washington, DC. 4. Lal, K & Goldberg, D. Histological Analysis of Human Skin Indicates Quantitative Increase of Collagen and Elastin Fibers after Synchronized Radiofrequency with Facial Muscle Stimulation. Presented at American Society for Dermatologic Surgery (ASDS) Annual Meeting 2022, Denver, CO.
